These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9180368)

  • 1. Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease.
    Uemasu J; Nakaoka A; Kawasaki H; Ishikawa I; Yoshino Y; Shio H; Nemoto R; Nakamura I; Morio S
    Life Sci; 1997; 60(23):2139-44. PubMed ID: 9180368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
    Lee KB; Kim UK; Lee CC
    J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
    Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A
    Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease.
    Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD
    Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease.
    Schiavello T; Burke V; Bogdanova N; Jasik P; Melsom S; Boudville N; Robertson K; Angelicheva D; Dworniczak B; Lemmens M; Horst J; Todorov V; Dimitrakov D; Sulowicz W; Krasniak A; Stompor T; Beilin L; Hallmayer J; Kalaydjieva L; Thomas M
    Nephrol Dial Transplant; 2001 Dec; 16(12):2323-7. PubMed ID: 11733623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of angiotensin converting enzyme (
    Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
    Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.
    Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D
    Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease.
    van Dijk MA; Breuning MH; Peters DJ; Chang PC
    Nephrol Dial Transplant; 2000 Jun; 15(6):836-9. PubMed ID: 10831637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
    Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
    Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease.
    van Dijk MA; Peters DJ; Breuning MH; Chang PC
    J Am Soc Nephrol; 1999 Sep; 10(9):1916-20. PubMed ID: 10477143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE.
    Uhm WS; Lee HS; Chung YH; Kim TH; Bae SC; Joo KB; Kim TY; Yoo DH
    Lupus; 2002; 11(4):227-33. PubMed ID: 12043886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Ecder T; McFann KK; Raynolds MV; Schrier RW
    Am J Nephrol; 2003; 23(6):466-70. PubMed ID: 14600431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD).
    Gumprecht J; Zychma MJ; Karasek D; Grzeszczak W
    Nephrol Dial Transplant; 2007 May; 22(5):1483. PubMed ID: 17205958
    [No Abstract]   [Full Text] [Related]  

  • 15. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
    Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
    Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polymorphism of the ACE gene affects left ventricular hypertrophy and causes disturbances in left ventricular systolic/diastolic function in patients with autosomal dominant polycystic kidney disease.
    Wanic-Kossowska M; Posnik B; Kobelski M; Pawliczak E; Pawlaczyk K; Hoppe K; Schwermer K; Sikorska D
    ScientificWorldJournal; 2014; 2014():707658. PubMed ID: 24672357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
    Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A
    Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
    Jacobsen P; Rossing K; Rossing P; Tarnow L; Mallet C; Poirier O; Cambien F; Parving HH
    Kidney Int; 1998 Apr; 53(4):1002-6. PubMed ID: 9551410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.